A minireview of E4BP4/NFIL3 in heart failure.

Area of Science:

• Cardiology
• Molecular Biology
• Biochemistry

Background:

• Heart failure (HF) is a leading cause of global morbidity and mortality.
• Impaired left ventricular myocardial function is a primary cause of HF, leading to severe congestion and edema.
• Novel therapeutic strategies are urgently needed to manage HF worldwide.

Purpose of the Study:

• To review the role of transcription factors (TFs) in HF pathogenesis.
• To investigate the expression, structure, and function of Adenovirus E4 promoter-binding protein (E4BP4) in cardiac signaling.
• To propose E4BP4 as a potential therapeutic target for HF.

Main Methods:

• Literature review focusing on molecular mechanisms of HF.
• Analysis of signaling pathways regulated by E4BP4, including calcium signaling, autocrine signaling, and IGF-II receptor-mediated processes.
• Discussion of E4BP4's role in cardiac physiology and pathology.

Main Results:

• E4BP4 (NFIL3) is a basic leucine zipper TF involved in regulating cardiac functions.
• E4BP4 modulates key signaling pathways implicated in HF, such as calcium signaling and autocrine signaling.
• E4BP4's involvement in insulin-like growth factor II receptor-mediated processes is highlighted.

Conclusions:

• E4BP4 plays a critical role in regulating signaling pathways relevant to HF pathogenesis.
• E4BP4 represents a promising novel therapeutic target for the development of new HF treatments.
• Further scientific investigation into E4BP4's role in HF is warranted.